Go Deep
AngioDynamics, Inc.
AngioDynamics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,757 | -14.0 | 2.68 | 0.07 | 1,038.05 |
| Oct 2026 | 19,692 | -14.2 | 2.72 | 0.07 | 1,049.17 |
| Oct 2026 | 19,464 | -14.7 | 2.85 | 0.07 | 1,099.65 |
| Oct 2026 | 19,610 | -14.2 | 2.77 | 0.07 | 1,064.60 |
| Oct 2026 | 19,545 | -14.6 | 2.80 | 0.07 | 1,079.96 |
| Oct 2026 | 19,364 | -15.1 | 2.91 | 0.07 | 1,119.78 |
| Oct 2026 | 19,330 | -15.2 | 2.93 | 0.07 | 1,124.58 |
| Oct 2026 | 19,274 | -15.4 | 2.96 | 0.07 | 1,134.58 |
AngioDynamics, Inc. Quarterly Results
| Line Item | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 |
|---|---|---|---|---|
| Revenue | 86,607,000.0 | 78,423,000.0 | 79,433,000.0 | 75,711,000.0 |
| Net Profit | -11,405,000.0 | -8,084,000.0 | -6,350,000.0 | -10,903,000.0 |
| EPS | -0.3 | -0.2 | -0.1 | -0.3 |
AngioDynamics, Inc. Revenue & Profit: Last 5 Years
| Line Item | May 2026 | May 2025 | May 2024 | May 2023 | May 2022 |
|---|---|---|---|---|---|
| Revenue | 320,174,000.0 | 292,498,000.0 | 303,914,000.0 | 338,752,000.0 | — |
| Net Profit | -36,742,000.0 | -33,993,000.0 | -184,349,000.0 | -52,442,000.0 | — |
| EPS | -0.9 | -0.8 | -4.6 | -1.3 | — |
AngioDynamics, Inc. Balance Sheet
| Line Item | May 2026 | May 2025 | May 2024 | May 2023 | May 2022 |
|---|---|---|---|---|---|
| Total Assets | 267,163,000.0 | 280,144,000.0 | 317,671,000.0 | 532,637,000.0 | — |
| Total Liabilities | 96,338,000.0 | 97,174,000.0 | 112,085,000.0 | 154,341,000.0 | — |
| Total Equity | 170,825,000.0 | 182,970,000.0 | 205,586,000.0 | 378,296,000.0 | — |
Owes vs Owns
AngioDynamics, Inc. owed $0.36 for every $1 it owned in May 2026, up from $0.29 in May 2023.
| Period | May 2026 | May 2025 | May 2024 | May 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.36× | 0.35× | 0.35× | 0.29× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
AngioDynamics, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — May 2026
Cash & short-term investments 20.2%Receivables 18.2%Inventory 19.6%Fixed assets (tangible) 10.1%Intangible assets 25.2%Other assets 6.8%
How it's funded — May 2026
Payables 11.8%Other liabilities 24.3%Shareholders' equity 63.9%
| Line Item | May 2026 | May 2025 | May 2024 | May 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 53.9 | 55.9 | 76.1 | 44.6 |
| Receivables | 48.5 | 43.1 | 50.0 | 52.8 |
| Inventory | 52.4 | 62.0 | 60.6 | 55.3 |
| Fixed assets (tangible) | 27.1 | 32.3 | 35.7 | 44.4 |
| Intangible assets | 67.2 | 69.1 | 77.4 | 270.4 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 18.0 | 17.7 | 17.9 | 65.1 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 4.7 | 14.8 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 49.8 |
| Payables | 31.5 | 33.3 | 37.8 | 40.4 |
| Other liabilities | 64.8 | 63.9 | 69.6 | 49.3 |
| Shareholders' equity | 170.8 | 183.0 | 205.6 | 378.3 |
| Net tangible assets | 103.6 | 113.9 | 128.2 | 107.9 |
AngioDynamics, Inc. Cash Flow
| Line Item | May 2026 | May 2025 | May 2024 | May 2023 | May 2022 |
|---|---|---|---|---|---|
| Operating Activities | 3,089,000.0 | -10,128,000.0 | -28,158,000.0 | 78,000.0 | — |
| Investing Activities | -5,949,000.0 | -10,178,000.0 | 123,717,000.0 | -9,746,000.0 | — |
| Financing Activities | 564,000.0 | -255,000.0 | -64,248,000.0 | 25,420,000.0 | — |